Accordingly, high SLAMF6 levels are a surrogate indicator for immune-favorable tumor microenvironments of breast cancer and melanoma; SLAMF6high tumors are significantly enriched with gene expression patterns associated with T cell activation and effector functions [37]. This evidence concerns the gene SLAMF6 and breast carcinoma.